(No Ratings Yet)
Loading...4 views
Updated: June 3rd, 2022 | Boston | Lawyer List T | Greene LLP |
The current rating on Thomas M. Greene is
(No Ratings Yet)Loading...And receives 4 page views
Address: One Liberty Square, Suite 1200, boston, MA, 02109
Law Firm: Greene LLP
Phone: 857-400-7388
Fax: 617-507-6559
Email:
Website: http://www.greenellp.com
| Title | Managing Partner |
| First Year of Call | |
| Areas of Practice | Complex Litigation, Civil Litigation, Class Action, Plaintiffs Personal Injury, Fraud, Litigation |
| Description | Thomas M. Greene has concentrated his practice in complex civil litigation for more than thirty years. Mr. Greene has represented individuals in a wide variety of cases ranging from whistleblowers who have exposed corporate fraud to individuals who have suffered serious injury or death arising from defective products, aviation crashes, and other catastrophic accidents.Mr. Greene’s pharmaceutical litigation experiences have been chronicled in various publications including the New York Times, Wall Street Journal, USA Today, the Boston Globe, the British Medical Journal, The Lancet, the American Lawyer, and Trial magazine. In a seminal lawsuit against Parke-Davis and Pfizer, a qui tam whistleblower case that involved off-label marketing of the drug Neurontin, Mr. Greene established for the first time that off-label promotion of prescription drugs was fraud that could result in liability to the government under the False Claims Act. His work exposing illegal drug marketing by the pharmaceutical industry has been featured in the book Our Daily Meds by former New York Times reporter Melody Petersen, and he has also been featured on national radio and television shows, including National Public Radio, Canadian Broadcasting Company, and NBC’s Dateline for his work in pharmaceutical litigation. Mr. Greene also recently published an article in Trial magazine entitled A New Weapon in Pharma Cases about the use of the Racketeer Influenced & Corrupt Organizations Act against pharmaceutical companies.Mr. Greene is a frequent speaker at national conferences and summits, often related to his experience with the False Claims Act and representing qui tam whistleblowers. As Chair and Moderator, Mr. Greene recently led a two-day program entitled Recent Developments in False Claims Act Litigation, at which recent legislative changes to the False Claims Act were discussed. Mr. Greene has also been invited to speak about off-label promotion at Johns Hopkins University, Harvard Law School, Boston College, and Northwestern Law School.Mr. Greene understands being at the helm of multi-district litigation. He was appointed to the Plaintiffs’ Steering Committee of In re Air Crash Disaster, an MDL arising from the crash of American Eagle Flight 3379 on approach to the Raleigh-Durham International Airport. He was also appointed to the Plaintiffs’ Steering Committee in the MDL arising from off-label promotion of Neurontin, In re Neurontin Marketing and Sales Practices, and was elected its Chairman. In 2010, a bellwether case for the MDL was tried on behalf of Kaiser Foundation Health Plan, leading to a trebled jury verdict of $142 million under RICO and a $102 million judgment under the California Unfair Competition Law. Later that year, Mr. Greene won Most Compelling Argument at the 2010 Massachusetts Battle of the Lawyers for a reprisal of his closing argument in the Kaiser case.Mr. Greene received his law degree from Suffolk University Law School in 1977. He graduated cum laude from Boston College in 1974.Presentations and Seminars:Witness, United States House of Representatives, Energy & Commerce Subcommittee on HealthFebruary 27, 2013, Washington, DCFostering Innovation in Fighting Health Care Waste, Fraud, and AbusePanelist, ABA Antitrust Law Section, Health Care and Pharmaceuticals CommitteeJanuary 11, 2013, Washington, DCOff-Label Promotion of Pharmaceuticals: Application of the False Claims Act and Consumer Protection Act to Promotional StrategiesGuest Lecturer, Boston College Carroll School of ManagementNovember 10, 2011, Chestnut Hill, MALaw of MarketingChair and Moderator, Suffolk University Law School Advanced Legal StudiesMarch 24 and 31, 2011, Boston, MARecent Developments in False Claims Act LitigationSeminar, Johns Hopkins University School of Public Health, Center for Clinical TrialsFebruary 9, 2011, Baltimore, MDHow Industry Distorted the Scientific Evidence and Turned ˜Snake Oil’ Into a $10 Billion Blockbuster: Lessons for Public HealthPanelist, American Association of Justice Winter Meeting, Sunrise at LitigationFebruary 8, 2011, Miami, FLHow to Win a RICO Case Against a Pharmaceutical Giant for Fraudulent Off-Label PromotionWinner, Most Compelling Argument, Sixth Annual Battle of the LawyersNov 4, 2010, Boston MAMassachusetts Lawyers WeeklyPanelist, Northwestern Law Judicial SymposiumMay 3 5, 2009, Chicago, ILThe Pharmaceutical Industry: Economics, Regulation and Legal IssuesPanelist, Annual Whistleblower Law SymposiumMarch 4, 2009, Atlanta, GA, State Bar of GeorgiaRecent Developments in Qui Tam Cases Under the False Claims Act The Relator’s PerspectiveModerator, Eighth Annual Taxpayers Against Fraud Education Fund Conference & Awards DinnerSeptember 7 10, 2008, Washington, DCFraud-Fighting Pioneers: Moving the FCA in New DirectionsPanelist, The Seventh Annual Pharmaceutical Compliance Congress and Best Practices ForumNovember 8 10, 2006, Washington, DCQui Tam Update PanelPanelist, Health Care Fraud Enforcement in the Pharmaceutical SectorSeptember 25, 2006, Cambridge, MA, Harvard Law School Ethics, Law & Biotechnology SocietyModerator, Sixth Annual Taxpayers Against Fraud Education Fund Conference & Awards DinnerSeptember 10 13, 2006, Washington, DCFraud-Fighting Pioneers: Moving the FCA in New DirectionsPanelist, The Second Annual FDA Regulatory and Compliance SymposiumAugust 22 25, 2006, Cambridge, MALessons from Whistle-Blower CasesPanelist, The 6th Annual National Institute on Civil False Claims Act and Qui Tam EnforcementJune 14 16, 2006, Washington, DCFCA Enforcement Against Pharmaceutical Companies and Medicare/Medicaid ProvidersParticipant, The Sedona Conference Complex Litigation VII: Litigating Mass TortsApril 7 8, 2005, Sedona, AZPanelist, The International Pharmaceutical Compliance Summit on Medical Affairs, Clinical Trials, Safety and PublicationMarch 30 April 1, 2005, Philadelphia, PAQui Tam Update PanelKeynote Speaker, The 2nd Annual Pharmaceutical Marketing Compliance CongressJanuary 31 February 1, 2005, Washington, DCThe Growing Role of WhistleblowersPanelist, The Fifth Annual Pharmaceutical Regulatory and Compliance CongressNovember 14 17, 2004, Washington, DCQui Tam Update PanelPanelist, Fourth Annual Conference for Qui Tam Relators’ CounselOctober 14 and 15, 2004, Washington, DCThe Federal Food, Drug and Cosmetic Act and Its Application to Qui Tam: Pharmaceutical and Medical Device CasesFaculty, National Pharma Audio conference: Lessons of the Pfizer Settlement for Off-Label Promotion Compliance Issues and PracticesJune 23, 2004 |
Complex civil litigation attorneys, with a focus on representing qui tam whistleblowers in False Claims Act cases, nationwide.Greene LLP specializes in representing plaintiffs in complex civil litigation. Handling both business disputes and serious personal injury claims, we believe clients are best served when their lawyers share their economic interests. Consequently, we handle most of our cases on a contingency basis. We believe client…
David P. Cherundolo
Strout & Payson P.A.
Eric M. Martin Attorney
Patrick H. Tate P.A.
The Ted Kanner Law Office
Conliffe Sandmann & Sullivan
John R. Hakanson
Hoeppner Wagner & Evans LLP
Darrell R. Avery Attorney at Law
Kellogg Hansen Todd Figel & Frederick P.L.L.C.
Beaver Courie Sternlicht Hearp & Broadfoot P.A.
Bleakley Bavol Denman & Grace
Petersen & Lefkofsky P.C.
Mooty & Associates P.C. Attorneys at Law
Wood Smith Henning & Berman LLP
Cicchetti Tansley & McGrath LLP
